3rd Quarter - Report
W STRATEGIES, LLC for MERCK & CO., INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R.107: to sunset the limit on the maximum rebate amount for single source drugs. Proposed legislative and regulatory proposals in the Administrations Rx Blueprint. H.R.3: Lower Drug Costs Now Act of 2019. S.2543: Prescription Drug Pricing Reduction Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.